Blackstone Inc’s Day One Biopharmaceuticals DAWN Stock Holding History

Blackstone Inc’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-41,567	Closed	-$891K	–	562
2026 Q1	$891K	Buy	+41,567	New	+$586K	﹤0.01%	252

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Blackstone Inc's DAWN Position: Q2 2026 in Review

Blackstone Inc sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 41,567 shares — an estimated $891K sold.

Blackstone Inc first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $891K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Blackstone Inc reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Blackstone Inc sold 41,567 Day One Biopharmaceuticals shares in Q2 2026, an estimated $891K.
Blackstone Inc first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Blackstone Inc's Day One Biopharmaceuticals position peaked at $891K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.